We provide testing services to certify product and materials compliance, support quality control, and ensure the health and safety of workers and their environment. We provide assistance for clients who are not sure what tests they need. Our accredited materials characterization laboratory is the foundation of all the services of RJ Lee Group provides, including standardized testing for compliance, industrial hygiene and environmental analyses, quality control, and materials research and development.

We provide credentialed expertise supported built by robust scientific data. We provide significant support to industrial clients for product development, industrial hygiene and overall production support.

RJ Lee Group maintains a visible and respected reputation within the legal community, having offered scientific support in civil litigation matters for nearly 30 years. 

  • Product Liability 
  • Toxic Tort
  • Construction Defect
  • Fugitive Emission
  • Personal Injury
  • Patent Infringement
  • Contract Disputes
  • Insurance Subrogation

Subject Matter Experts

From our core business of providing scientific solutions to our clients, we have developed innovative products. Some are produced internally, and some have arisen from partnerships with other research organizations. 

For example, we build lab software solutions to help manage and streamline your labs data, and environmental testing products for a variety of applications. 

  • IntelliSEM is a powerful automated particle analysis system.
  • ParticleID is  a customizable cloud hosted web application used to identify foreign particulate matter and  assist with root cause investigations. 

Other products we create count particles and help keep the air and environment safe.

RJ Lee Group is a materials analysis laboratory and consulting company which serves many different industries. We offer scientific solutions such as industrial forensics services, laboratory and testing services, litigation support, and laboratory software to many industries:

North Carolina Chinese Business Association (NCCBA) to Present Seminar “Beyond the Horizon” The Application of Nanotechnology in Personalized Medicine

RJ Lee Group News

June 14, 2011

Nanotechnology and Personalized Medicine are two of the most rapidly developing areas of biomedical research and the most promising technologies for improving healthcare and human life.

Dr. Lin Wu, Director of Biotechnology and Pharmaceutical Services at RJ Lee Group Inc., Monroeville, PA and one of the founding trustees of NCCBA will be the featured speaker in this NCCBA Leadership Speakers Series seminar. Dr. Wu will discuss one of the most active application areas of nanotechnology – nanomedicine – the application of nanotechnology to the medical advancement of therapeutics and diagnostics. He will relate his personal view on the potential applications of nanotechnology and personalized medicine as well as his recent return to the life science industry (RJ Lee Group Inc.) attracted by the firm’s nano-technological potential. He will share his personal journey, transitioning from academia to industry, from research to development, and from scientist to manager, the lessons learned, and the importance of looking beyond the horizon.

To register for this seminar, please contact: Ms. Mei Dai,

Linxian (Lin) Wu, Ph.D.

Dr. Wu is a seasoned executive in the life science industries who has worked in the pharmaceutical and biological products regulatory agencies both in China (SFDA) and Canada. He received his Ph.D. in Medical Microbiology and Infectious Diseases from University of Alberta, Canada and performed post-doctoral training in Molecular Virology at the Medical College of Pennsylvania. His industrial experience involves the areas of clinical diagnostics, therapeutic medical devices, and pharmaceuticals. He was Director of Research & Development at GenTrak Inc. (Philadelphia, Pa.); Executive Vice President and Chief Technology Officer at Gull Laboratories, Inc. (Salt Lake City, Utah), President and Chief Operating Officer at Fresenius Hemocare Inc. (Redmond, Wash.); and President and Chief Operating Officer at Fresenius Kabi Clayton LP (Clayton, N.C.). Currently Dr. Wu is the Director of Biotechnology and Pharmaceutical Services at RJ Lee Group Inc., a leading molecular imaging and trace materials analysis technology company with headquarters in Monroeville, PA.

Related Posts